Vertex pharmaceuticals and affinia therapeutics establish multi-year collaboration

Vertex pharmaceuticals and affinia therapeutics establish multi-year collaboration to discover and develop novel aav capsids for genetic therapies.vertex pharmaceuticals - affinia therapeutics will be eligible to receive over $1.6 billion in upfront & development, regulatory and commercial milestones.
VRTX Ratings Summary
VRTX Quant Ranking